Td Asset Management Inc Chemo Centryx, Inc. Transaction History

Td Asset Management Inc

$107 Billion
Q3 2024

Shares

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2020 Nov 10, 2020	SELL	$46.35 - $61.69 $641,530 - $853,851	-13,841 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$38.58 - $65.07 $155,631 - $262,492	4,034 Added 41.13%	13,841 $796,000
Q1 2020 May 15, 2020	BUY	$32.73 - $50.78 $320,983 - $497,999	9,807 New	9,807 $394,000
Q2 2018 Jul 31, 2018	SELL	$10.62 - $13.98 $215,585 - $283,794	-20,300 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$5.9 - $14.99 $119,770 - $304,297	20,300 New	20,300 $276,000

Others Institutions Holding CCXI

# of Institutions

6

Shares Held

66.3K

Call Options Held

0

Put Options Held

0

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.